Arizona Theatre Company Selects Next to Normal and Clybourne Park for 2012-2013 Season

News   Arizona Theatre Company Selects Next to Normal and Clybourne Park for 2012-2013 Season
Arizona audiences will get a look at two recent Pulitzer Prize-winning works as part of the Arizona Theatre Company's 2012-2013 season, which will be bookended by Next to Normal and Clybourne Park.

A.T.C. artistic director David Ira Goldstein will stage Next to Normal, which is a co-production with the San Jose Repertory Theatre. The Tony and Pulitzer Prize-winning musical about a woman battling with bipolar disorder is written by Tom Kitt (music) and Brian Yorkey (book and lyrics). It will run Sept. 15-Oct. 6 (Tucson) and Oct. 11-28 (Phoenix).

Eric Simonson's Lombardi, about Green Bay Packers coach Vince Lombardi, will receive its Southwest premiere Oct. 20-Nov. 10 (Tucson) and Nov. 15-Dec. 2 (Phoenix).

Tony Award nominee Jeff Calhoun (Newsies, Bonnie & Clyde) will direct the Arizona premiere of Paul Gordon's musical Emma, based on the Jane Austen novel, running Dec. 1-22 (Tucson) and Dec. 31-Jan. 20, 2013 (Phoenix).

A.T.C. will also align with San Jose Rep for a co-production of Mark St. Germain's Freud's Last Session. Stephen Wrentmore will direct the intimate work about the famous psychoanalyst that will run Jan. 19-Feb. 9, 2013 (Tucson) and Feb. 14-March 3, 2013 (Phoenix).

Goldstein will direct Neil Simon's The Sunshine Boys, about two veteran comedians who reunite to rehash their schtick, which will be presented March 2-23, 2013 (Tucson) and March 28-April 14, 2013 (Phoenix). Bruce Norris' acclaimed play Clybourne Park, which uses A Raisin in the Sun as a touchstone for a new look at race and real estate in America, will close the season April 6-27, 2013 (Tucson) and May 2-19, 2013 (Phoenix).

Tucson performances take place at the Temple of Music and Art (330 S. Scott Avenue); call the box office at (520) 622-2823. Phoenix performances take place at the Herberger Theater Center (222 E. Monroe Street); call the box office at (602) 256-6995.

Visit for more information.

Today’s Most Popular News:

Blocking belongs
on the stage,
not on websites.

Our website is made possible by
displaying online advertisements to our visitors.

Please consider supporting us by
whitelisting with your ad blocker.
Thank you!